Because of the downregulation of the ALOX15 gene, the suppressor or inhibitor of inflammation decreases, causing the pro-inflammatory agent to activate in the chronic inflammatory process that triggers nasopharyngeal cancer. The gene discussed is ALOX15; the disease is nasopharyngeal carcinoma.